NELLI BEJANYAN

Company: Moffitt Cancer Center

Job title: Program Leader of BMT

Seminars:

Audience Led Discussion: Pushing Pipeline into the Clinic 2:00 pm

Establishing a comprehensive understanding of the regulatory landscape for allogeneic off-the-shelf gamma delta T cell therapies Covering key aspects such as regulatory considerations for the future, prepping for a BLA, IND filing procedures and overall navigating the journey from IND filing to getting into the clinic Open mic for direct questions with industry KOLsRead more

day: Conference Day Two - Track B - PM

Clinical Case Study: Lessons Learned in Phase 1 12:00 pm

A step-by-step guide on preparing and submitting an IND application: Regulatory requirements for IND submission and best practices for engaging with regulatory agencies during the IND filing process Sharing lessons learned from being in the clinic, addressing unexpected regulatory challenges in the clinic and incorporating lessons learned into future development strategiesRead more

day: Conference Day Two - Track B - AM

Clinical Unpublished Data: Allogeneic Gamma Delta Immunotherapy for Acute Myeloid Leukemia 3:30 pm

Novel findings on VD2s and VD1s remain unpublished currently Research aims to evaluate the efficacy, safety, and potential benefits of gamma delta cell therapy in treating AcutAML Signifying the emergence of gamma delta cell therapy as a promising novel approach in AML managementRead more

day: Conference Day One